We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Koninklijke Philips NV | EU:PHIA | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.495 | 2.59% | 19.60 | 19.40 | 19.62 | 19.625 | 19.39 | 19.40 | 2,661,829 | 16:40:00 |
By Matteo Castia
Koninklijke Philips NV said Friday that it has included more targets in its 2021-25 growth plan, building on those announced in October.
The Dutch medical-technology group said it is now targeting accelerated sales growth and an adjusted earnings before interest, taxes, depreciation and amortization margin in the high-teens by 2025.
The company said it is also aiming for an extra 400 million euros ($473.2 million) of net savings a year between 2021 and 2025, in an effort to reach extra cumulative net savings of EUR2 billion by the end of that period.
Philips added that it is seeking to achieve mid-to-high-teens organic return on invested capital by 2025.
The company also reiterated the targets it had outlined in its third-quarter earnings on Oct. 19, when it said it was targeting an acceleration in the average annual comparable sales growth to 5%-6%, an adjusted Ebita margin improvement of 60-80 basis points on average annually from 2021 and a free cash flow above EUR2 billion by 2025.
Write to Matteo Castia at matteo.castia@dowjones.com
(END) Dow Jones Newswires
November 06, 2020 02:44 ET (07:44 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Koninklijke Philips NV Chart |
1 Month Koninklijke Philips NV Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions